Effect of Dutasteride and Imidafenacin in BPH/OAB patients not respond to eight weeks'continuous treatment of Tamsulosin.
Phase of Trial: Phase III
Latest Information Update: 28 Mar 2017
At a glance
- Drugs Imidafenacin (Primary) ; Dutasteride
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms DIrecT
- Sponsors Kyorin Pharmaceutical
- 16 Sep 2016 Results of subgroup analysis (n=163) presented at the 46th Annual Meeting of the International Continence Society.
- 07 Apr 2016 Status changed from active, no longer recruiting to completed.
- 15 Oct 2014 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan .